NCT02291016.
| Trial name or title | COPD aerosol study comparing the efficacy of nebulizers versus dry powder inhalers |
| Methods | Registered, currently running and unpublished randomised interventional trial. |
| Participants | Location: University of Tennessee,TN, USA Target: 30 participants Setting: unknown COPD definition: FEV1/FVC ratio ≤ 70% |
| Interventions | Comparison of dosage administered via a nebuliser versus dosage administered via a dry powder inhaler. 12 µg formoterol with the dry powder inhaler and 20 µg (solution form) of formoterol with the nebuliser Beta2 ‐agonist: formoterol DPI: brand not reported Nebuliser: brand not reported Dosage ratio DPI/nebuliser: 1:1.667 |
| Outcomes | The difference between the values of area under the response curve for FEV1 from baseline through 4 h (AUC FEV1 0 to 4 h), |
| Starting date | 2015 |
| Contact information | Contact: Lauren Davis; lsdavis@mc.utmck.edu; principal investigator: Rajiv Dhand, MD |
| Notes | NCT02291016 |
AUC: area under the curve; FEV1 : forced expiratory volume in 1 second; FVC: forced vital capacity